NEUROBLASTOMA - A CLINICAL CHALLENGE AND BIOLOGIC PUZZLE

被引：62

作者：

MATTHAY, KTK

机构：

[1] University of California School of Medicine, San Francisco, California

来源：

CA-A CANCER JOURNAL FOR CLINICIANS | 1995年 / 45卷 / 03期

关键词：

D O I：

10.3322/canjclin.45.3.179

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Neuroblastoma is the third most common malignancy in childhood and accounts for at least 15 percent of cancer-related deaths in children. The varied clinical behavior of this disease, ranging from spontaneous regression in some to progression while under aggressive therapy in others, has been associated with various biologic differences, providing insight into pathophysiology and possibilities for more specific treatments. This article reviews the epidemiology, pathophysiology, clinical evaluation? and treatment of neuroblastoma.

引用

页码：179 / 192

页数：14

共 76 条

[61]

Kushner BH, O'Reilly RJ, Mandell LR, Et al., Myeloablative combination chemotherapy without total body irradiation for neuroblastoma, J Clin Oncol, 9, pp. 274-279, (1991)

[62]

Dini G, Lanino E, Garaventa A, Et al., Myeloablative therapy and unpurged autologous bone marrow transplantation for poor‐prognosis neuroblastoma: Report of 34 cases, J Clin Oncol, 9, pp. 962-969, (1991)

[63]

Shuster JJ, Cantor AB, McWilliams N, Et al., The prognostic significance of autologous bone marrow transplant in advanced neuroblastoma, J Clin Oncol, 9, pp. 1045-1049, (1991)

[64]

Brenner MK, Rill DR, Moen RC, Et al., Gene marking and autologous bone marrow transplantation, Ann NY Acad Sci, 716, pp. 204-214, (1994)

[65]

Reynolds CP, Seeger RC, Vo DD, Et al., Model system for removing neuroblastoma cells from bone marrow using monoclonal antibodies and magnetic immunobeads, Cancer Res, 46, pp. 5882-5886, (1986)

[66]

Matthay KK, Seeger RC, Reynolds CP, Et al., Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: A report from the Childrens Cancer Group, J Clin Oncol, 12, pp. 2382-2389, (1994)

[67]

Matthay KK, Atkinson JB, Stram DO, Et al., Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: A Childrens Cancer Group pilot study, J Clin Oncol, 11, pp. 2226-2233, (1993)

[68]

Cheung NK, Lazarus H, Miraldi FD, Et al., Ganglioside GD2 specific monoclonal antibody 3F8: A phase I study in patients with neuroblastoma and malignant melanoma, J Clin Oncol, 5, pp. 1430-1440, (1987)

[69]

Murray JL, Cunningham JE, Brewer H, Et al., Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors, J Clin Oncol, 12, pp. 184-193, (1994)

[70]

Hank JA, Surfus J, Gan J, Et al., Treatment of neuroblastoma patients with antiganglioside G<sub>D2</sub> antibody plus interleukin‐2 induces antibody‐dependent cellular cytotoxicity against neuroblastoma detected in vitro, J Immunother, 15, pp. 29-37, (1994)

← 1 2 3 4 5 6 7 8 →